Internal Medicine, Infectious Disease · Laurel, MS
NPI
1770597882
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1440 Jefferson St
Laurel, MS, 39440
Phone (601) 428-0577
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$483K
409 prescriptions
Company payments, 2025
$60.88
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Thomas E Dobbs prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 62 prescriptions and refills. In total Thomas E Dobbs wrote 409 Medicare prescriptions that cost $483K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 62 | 62 | Under 11 | $234K |
| Isoniazid Generic | 52 | 52 | 23 | $199 |
| Priftin Rifapentine | 35 | 35 | 16 | $3,768 |
| Rifampin Generic | 29 | 29 | Under 11 | $2,802 |
| Pyrazinamide Generic | 17 | 17 | Under 11 | $3,967 |
| Ethambutol Hcl Generic | 17 | 17 | Under 11 | $1,668 |
| Rifabutin Generic | 16 | 16 | Under 11 | $9,971 |
| Juluca Dolutegravir/Rilpivirine | 15 | 15 | Under 11 | $50K |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 15 | 15 | Under 11 | $32.85 |
| Tivicay Dolutegravir Sodium | 14 | 14 | Under 11 | $30K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 14 | 14 | Under 11 | $62K |
| Mupirocin Generic | 12 | 13 | Under 11 | $65.88 |
Brand drugs: 176 claims; generic drugs: 233 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas E Dobbs $60.88 ($60.88 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $60.88.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $60.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.